28
Oct
2025

Fujian Genohope Biotech Ltd

Exhibitor at CPHI Frankfurt 2025 stand 3.0A88, Finished Dosage Formulations
About Us

Fujian Genohope Biotech Ltd. manufacture Semaglutide via both synthetic and fermention routes respectively, and we also have Tirzepatide. We belong to New Hope Group, one of the world's top 500 enterprises.We are FDA-approved GMP facility and producing Semaglutide DMFs (recombinant and synthetic) with NDCs.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Consumer Goods
Primary activities
API Producer
View company profile
Contact info
  • 86-05948880288
  • Website
  • No.288 Xitang Street, Hushi l. Park,, Xiuyu District, 351146, Putian City, Fujian, China
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.0A88, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Fulvestrant

    Product Fulvestrant

    Fulvestrant API, injectable grade,  US cGMP compliant
  • Liraglutide

    Product Liraglutide

    Liraglutide, synthetic API, GLP-1, US cGMP compliant, Tech Transfer available
  • SEMAGLUTIDE

    Product SEMAGLUTIDE

    Our main product is Semaglutide API and Injection.We manufacture Semaglutide via both synthetic and fermention routes respectively, and we also have Tirzepatide. We belong to New Hope Group, one of the world's top 500 enterprises.We are FDA-approved GM...
  • TIRZEPATIDE

    Product TIRZEPATIDE

    Our main product is Semaglutide API and Injection.We manufacture Semaglutide via both synthetic and fermention routes respectively, and we also have Tirzepatide. We belong to New Hope Group, one of the world's top 500 enterprises.We are FDA-approved GM...